Pharmacogenomic Testing Markets

Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the market due to adverse reactions in some, but not all, of the patients to whom they were administered. Additionally, reducing the occurrence of adverse effects to a drug effectually reduces the cost of patient care overall. This TriMark Publications study examines the market for diagnostic tests based on this science and the clinical measurement methods, the reagents and supplies being utilized in clinical medicine and the pharmaceutical industry. This report presents an overview of the latest information regarding emerging new products and industry trends and will not only quantify, but also, qualify the pharmacogenomic market segments as an area of research, product development and investment opportunity. Forecasts of the pharmacogenomic market and an analysis of products in the worldwide diagnostics market will provide a basis for understanding the significance of past developments and the immense possibilities of the future. The principal objectives of this study are to:

· Identify viable technology drivers through a comprehensive look at various platform technologies for pharmacogenomic testing segments of the diagnostic testing markets.

· Obtain a complete understanding of the important pharmacogenomic targets and their diagnostic test value, and to gain an understanding of these elements from their basic principles to their applications.

· Discover feasible market opportunities by identifying high-growth applications in different pharmacogenomic diagnostic testing areas, with a focus on the largest and expanding markets concerned with diseases.

· Focus on global industry development through an in-depth analysis of the major world markets for pharmacogenomic diagnostic testing.

· Present market figures regarding the current value of the pharmacogenomic testing market, projections and growth rates.

· Examine the use of pharmacogenomic testing in pharmaceutical drug development and show specific examples of its use in development and repositioning of therapeutic agents.

April, 2008 Pages: 162 Format: PDF
Table of Contents
Price: $3,400.00 / GBP1,700.00